Impact of early dose intensity on cytogenetic and molecular responses in chronic- phase CML patients receiving 600 mg/day of imatinib as initial therapy
Titel:
Impact of early dose intensity on cytogenetic and molecular responses in chronic- phase CML patients receiving 600 mg/day of imatinib as initial therapy
Auteur:
Hughes, Timothy P. Branford, Susan White, Deborah L. Reynolds, John Koelmeyer, Rachel Seymour, John F. Taylor, Kerry Arthur, Chris Schwarer, Anthony Morton, James Cooney, Julian Leahy, Michael F. Rowlings, Philip Catalano, John Hertzberg, Mark Filshie, Robin Mills, Anthony K. Fay, Keith Durrant, Simon Januszewicz, Henry Joske, David Underhill, Craig Dunkley, Scott Lynch, Kevin Grigg, Andrew